# Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients

Source: https://onco.cc/trials/nct07062263/  
OnCo record `nct07062263` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of trastuzumab in gallbladder cancer and other biliary tract cancers, run by Tata Memorial Centre, now recruiting.

## Summary

Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients is a phase 3, randomised interventional study registered as NCT07062263 by Tata Memorial Centre, with a registry enrolment figure of 220 participants, started 2023-07-21 and due to reach its primary completion in 2029-07-31. Interventions recorded: Trastuzumab, Chemotherapy. Conditions listed: Biliary Tract Cancer, HER2-positive Cancer, Advanced Cancer, Unresectable Biliary Tract Carcinoma, Metastatic Biliary Tract Carcinoma. Gallbladder cancer is named in the registry entry: "1. Biliary tract cancers include gallbladder cancer, intrahepatic cholangiocarcinoma, and perihilar cholangiocarcinoma.". Sites: India. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: TAB-2
- Tags: ctgov-ingest; gallbladder-deep-dive
- Registry id: NCT07062263
- Phase: 3
- Setting: Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients - a Randomized Non-blinded Two-arm Phase III Prospective Clinical Trial (TAB-2 Study).
- Sponsor: Tata Memorial Centre
- Enrolled: 220

## Sources

- ClinicalTrials.gov NCT07062263: https://clinicaltrials.gov/study/NCT07062263

## Connected records

- cancers: [Biliary tract cancer (all types)](https://onco.cc/cancers/biliary-tract-cancer/), [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/), [Extrahepatic cholangiocarcinoma (perihilar and distal)](https://onco.cc/cancers/extrahepatic-cholangiocarcinoma/), [Gallbladder cancer](https://onco.cc/cancers/gallbladder/), [Intrahepatic cholangiocarcinoma](https://onco.cc/cancers/intrahepatic-cholangiocarcinoma/)
- technologies: [Monoclonal antibodies](https://onco.cc/technologies/monoclonal-antibody/)
- drugs: [Trastuzumab](https://onco.cc/drugs/trastuzumab/)
- terms: [Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups)](https://onco.cc/terms/gallbladder-cancer-in-biliary-trials/)

---
JSON: https://onco.cc/api/v1/entities/nct07062263.json